Latest equities thinking

  • Chemical compounds: The good, the bad and the ugly

    9 Dec 2020

    After decades of secrecy, light is increasingly being shone on the potentially hazardous compounds produced by chemical companies. In the latest instalment of our editorial series, Link, experts from Aviva Investors’ credit, equities and ESG teams discuss the prevalence of chemicals in modern life, and how to balance usefulness and safety.

  • Pricing power is the magic ingredient for equity investors

    27 Nov 2020

    Evidence that a company wields pricing power in its industry is the best indication of a sustainable competitive advantage, argues Giles Parkinson.

  • Once bitten, twice shy: Is there value in tech by avoiding the FAANGs?

    30 Oct 2020

    The gravity-defying rally in technology shares has led some commentators to draw comparisons with the bubble of the late 1990s. However, Mikhail Zverev and Alistair Way believe there are still opportunities to be found in some of the sector’s less-fashionable stocks.

  • US Election 2020: Expect the unexpected

    29 Oct 2020

    As the US presidential election looms, we explore potential scenarios – from a Democratic “blue sweep” to a Trump re-election to a divided government – and assess the implications for investors.

  • Turn and face the change: How to invest dynamically in an uncertain world

    21 Oct 2020

    Equity markets are slow to price in the implications of change. This creates opportunities for dynamic, style-agnostic investors to take advantage, argue Caroline Galligan and David Cumming.

  • Don’t feed the troll: Social media companies face reckoning over hate speech

    28 Sep 2020

    Facebook, Twitter and other platforms are drawing criticism for their failure to tackle hate content. But will the hit to their reputation do any lasting commercial damage?

  • Investing in the gut: Fixing the bacterial bugs in our microbiome

    21 Sep 2020

    COVID-19 has intensified interest in the human microbiome, as researchers contemplate whether bacteria living in the gut might affect susceptibility to infection. Drawing on our experience in public markets and Ahren Innovation Capital’s knowledge of private markets, we look at the companies making strides in live biotherapeutics, using ‘bugs as drugs’, and key challenges that need to be overcome.

  • Why limit yourself? The benefits of style-agnostic investing

    16 Sep 2020

    Investors wanting to consistently exploit market inefficiencies should leave style biases behind, argues Mikhail Zverev.

  • Out with the old: Why income investors must be on the right side of change

    2 Sep 2020

    It has been a difficult year for income investing, as many companies have announced cuts or suspensions to dividends. But there are opportunities for investors willing to do some digging to find resilient businesses, says Richard Saldanha.

  • The clockmaker and the longitude problem: A lesson for investors in bottom-up problem solving

    25 Aug 2020

    Bottom-up thinking is not a typical hallmark of multi-asset investing. However, Francois de Bruin believes the granularity that comes from this approach offers useful diversification and risk benefits.

  • Electric avenue: EVs and the transformation of autos

    13 Aug 2020

    In the latest instalment of our editorial series, Link, experts from our infrastructure, credit research and equity teams discuss why efforts to ‘build back better’ as economies recover from COVID-19 could further accelerate investment in electric vehicles and associated infrastructure.

  • Chinese equities: A rally of substance?

    12 Aug 2020

    Chinese equities have risen sharply in recent weeks, mirroring trends in global markets. While some commentators have warned efforts by Beijing to juice share prices are inflating an unsustainable bubble, Alistair Way and Xiaoyu Liu argue valuations are far from excessive.

Subscribe to AIQ

Receive our award-winning insight on key investment themes, direct to your inbox.

AIQ Investment Thinking

Get our perspective on key themes influencing investment markets globally.
Read more

House View

A quarterly publication which encapsulates the thinking of our investment team.

Read more